Potential Allergan (AGN), Pfizer (PFE) Tie-Up No Surprise But May Take $400 to Get Done

Allergen (AGN)/Pfizer (PFE) Deal Creates Mid-Teens Synergies in Year 2 - RBC Capital

October 29, 2015 10:40 AM EDT

The potential Allergan (NYSE: AGN)/Pfizer (NYSE: PFE) deal would bring attractive strategic and financial aspects and focus will shift to the likelihood of actually getting done if the price is right and management structure can be agreed... More

Pfizer (PFE) Confirms Discussions with Allergan (AGN)

October 29, 2015 10:10 AM EDT

Pfizer (NYSE: PFE) notes the announcement by Allergan (NYSE: AGN) that was released earlier today regarding a potential transaction between the companies. Pfizer confirms that it is in preliminary friendly discussions with Allergan in relation to a potential... More

Pfizer (PFE) Offering $375 - $400/Share for Allergan (AGN) Might Seal Deal - Leerink

October 29, 2015 10:07 AM EDT

Leerink is out with commentary on Allergan (NYSE: AGN) following news that it and Pfizer (NYSE: PFE) are in talks over a potential deal.

Analyst Jason Gerberry is updating his Pfizer-Allergan model, which assumes at $375 per Allergan share takeover price. The analyst commented:

Following recent speculation that PFE (MP) and AGN are in discussions around a potential merger, we weigh in on (1) price; (2) people factor; (3) AGN M&A... More

Allergan (AGN) Affirms Talks with Pfizer (PFE)

October 29, 2015 9:31 AM EDT

Allergan (NYSE: AGN) confirmed that it has been approached by Pfizer Inc. and is in preliminary friendly discussions regarding a potential business combination transaction. Allergan stated that no agreement has been reached and there can be no certainty that these discussions... More

Pfizer needs a big deal, analysts say; Allergan 'makes sense'

October 29, 2015 7:39 AM EDT

(Reuters) - Allergan Plc's shares soared as much as 16 percent in premarket trading on Thursday, a day after media reports that Pfizer Inc had held early talks with the Botox-maker about a deal that would create the world's biggest drugmaker.

A combination of Dublin-based Allergan with New York-based Pfizer would create a $330-billion pharma giant and extend an unprecedented wave of consolidation in the industry as companies seek access to new drugs and increased leverage on pricing.

Maxim Jacobs, an analyst at Edison Investment Research, said a deal would make sense for Pfizer.

"Pfizer desperately needs... More

Pfizer (PFE), Allergan (AGN) in Talks About Blockbuster Deal - WSJ

October 28, 2015 9:34 PM EDT

Pfizer (NYSE: PFE) and Allergan (NYSE: AGN) are considering a merger the Wall Street Journal reported late Wednesday, citing people familiar with the matter.

Pfizer has approached Allergan about a... More